Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,443 | -14,489 | -72,627 | -56,968 | -36,010 |
| Depreciation Amortization | 1,510 | 836 | 6,774 | 6,560 | 1,099 |
| Accounts payable and accrued liabilities | -924 | -136 | -67 | 5 | 394 |
| Other Working Capital | -1,298 | -1,366 | -1,621 | -3,061 | 1,343 |
| Other Operating Activity | 5,350 | 1,938 | 13,577 | 12,230 | 8,840 |
| Operating Cash Flow | $-24,805 | $-13,217 | $-53,964 | $-41,234 | $-24,334 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,164 | 4,931 | 70,253 | 62,069 | 40,661 |
| PPE Investments | -4,683 | -2,186 | -809 | -652 | -382 |
| Investing Cash Flow | $-33,847 | $2,745 | $69,444 | $61,417 | $40,279 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 100 | 100 | 100 |
| Debt Repayment | -56 | -28 | -175 | -118 | -88 |
| Common Stock Issued | 2,771 | 162 | 71,215 | 71,025 | 70,909 |
| Other Financing Activity | -1,204 | -504 | -1,191 | -1,037 | -936 |
| Financing Cash Flow | $1,511 | $-370 | $69,949 | $69,970 | $69,985 |
| Beginning Cash Position | 155,948 | 155,948 | 70,519 | 70,519 | 70,519 |
| End Cash Position | 98,807 | 145,106 | 155,948 | 160,672 | 156,449 |
| Net Cash Flow | $-57,141 | $-10,842 | $85,429 | $90,153 | $85,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,805 | -13,217 | -53,964 | -41,234 | -24,334 |
| Capital Expenditure | -4,683 | -2,186 | -809 | -652 | -382 |
| Free Cash Flow | -29,488 | -15,403 | -54,773 | -41,886 | -24,716 |